# Geoffrey Von Maltzahn

Top podcast episodes
Updated:

Gene Writing: New Tech to Correct Disease

Gene editing is a relatively new technology that has revolutionary applications in agriculture and medicine.  The drawback to the technology is that it typically can only be used to disrupt a deleterious gene underlying a specific trait.  Gene writing exploits a natural process in cells that allows…

Creating the Next Groundbreaking Company with Geoffrey von Maltzahn, Biological Engineer and Serial Entrepreneur

Engineering is in Geoffrey’s blood. He’s a fourth-generation engineer who fell in love with the possibilities of the biotechnology revolution. Geoffrey combined his passion for biological engineering with savvy entrepreneurship to create startups that are pioneering groundbreaking therapies and med…

A Designer Seed Company Is Building a Farming Panopticon

When Geoffrey von Maltzahn was first pitching farmers to try out his startup’s special seeds, he sometimes told them, half-acknowledging his own hyperbole, that “if we’re right, you shouldn’t just see results in the field, you should be able to see them from outer space.” As the co-founder of a com…

The Scientist Using AI to Engineer the Next Generation of Drugs: Geoffrey von Maltzahn

Venture into the realm of biotech entrepreneurship with Geoffrey von Maltzahn, the mastermind behind a multitude of ground-breaking companies that fuse biology and data science to revolutionize human health and sustainability. Named among Bloomberg's 50 Ones to Watch, Business Insider's 30 Biotec…

Cracking the code: How generative biology could transform medicine

Can AI unravel the mysteries of human biology? Could it help design specialty treatments and cures for disease? Geoffrey von Maltzahn and his team at Generate:Biomedicines are bullish on both counts. AI has greatly accelerated progress in genome engineering, bioengineering and nanotechnology and th…

How Lila Is Redefining Scientific Discovery With Geoffrey von Maltzahn

In this episode of For Your Innovation, Brett Winton, along with ARK Invest Chief Investment Strategist, Charles Roberts, and Research Analyst, Nemo Marjanovic, sit down with Geoffrey von Maltzahn, CEO and founder of Lila Sciences and a general partner at Flagship Pioneering. Fresh out of stealth m…

SpaceX IPO Set to Hit $2 Trillion Valuation - Breaking! | OWITH Daily

Good morning from OWITH.ai: the podcast that gives you only what's important to hear in the AI and tech world. The conversation begins with the recent excitement surrounding SpaceX's IPO, poised to make history with a staggering valuation between $1.5 trillion and $2 trillion. Alongside potential …

National AI Policy with Joe Lonsdale & LILA Sciences

[Monty2026: Geopolitics, National Security, & Government] Joe Lonsdale (Founder & Managing Partner, 8VC) and Geoffrey von Maltzahn (Co-Founder & CEO, LILA Sciences) discuss national AI policy with moderator Martin Giles (Policy Fellow & Executive Director, Hoover Technology Policy Accelerator, The…

How AI Labs Build Scientific Superintelligence w/Geoffrey von Maltzahn Co-Founder & CEO of Lila

What if the next leap in science comes from a machine that runs the scientific method itself, around the clock, rather than from training on more of the internet? It would propose a hypothesis, design the decisive experiment and learn from the result. In this episode of Catalio Conversations, Marth…